| Cancer / Oncology News |
|
FDA Announces New Labeling Changes For Regranex | 09 June 2008 |
|
Link Between Chronic Inflammation And Cancer Confirmed | 09 June 2008 |
|
Author Reveals What Feeds Cancer | 09 June 2008 |
|
Delays In Diagnosing Teenagers And Young Adults With Cancer: Patients And Doctors Need Education And Simpler Referral Systems, UK | 09 June 2008 |
|
Young Patient Waited Ten Months Before Being Diagnosed With Cancer After A Catalogue Of Referral Errors, UK | 09 June 2008 |
|
UCLA Researchers Develop New PET Scanning Probe That Will Allow Modeling And Monitoring Of The Immune System | 08 June 2008 |
|
Improving Cancer Diagnosis And Support Services For Asian Patients | 07 June 2008 |
|
Precancerous Lesions Of The Endometrium: Uterus And Fertility Can Be Preserved | 07 June 2008 |
|
MRI Useful And Reliable In Surgical Planning Of Patients With Rectal Cancer | 07 June 2008 |
|
Amgen And Wyeth Statement On The FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers | 06 June 2008 |
|
For Some Patients, Cancer Is Just Half The Battle | 06 June 2008 |
|
The Long-Term Impact Of Childhood Cancer | 06 June 2008 |
|
Scientists Try To Develop Anti-Cancer Meat, Eggs | 06 June 2008 |
|
Fastest Ever Treatment For Cancer Patients | 06 June 2008 |
|
BioCurex Develops NEW Format For Its RECAF Cancer Blood Test - Results Confirm Its Accuracy | 06 June 2008 |
|
Synthetic Molecules Hold Promise For New Family Of Anti-Cancer Drugs | 06 June 2008 |
|
Relay Is The Way To Help Cancer Research UK | 06 June 2008 |
|
FDA Investigating Arthritis Drugs And Cancer Risk In Children | 05 June 2008 |
|
Malignant Melanoma Classification Given Additional Genetic Component | 05 June 2008 |
|
Laser Technique Fights Cancer With Light | 05 June 2008 |
|
Semafore Pharmaceuticals Reports Positive Interim Results From A Phase I Study Of SF1126, A Targeted Pan-PI3K Inhibitor | 05 June 2008 |
|
Promising Data On Head And Neck Cancer Announced By DNAR At 2008 American Society Of Clinical Oncology Meeting | 05 June 2008 |
|
Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results Of Azedra™ Phase I Trial In Neuroendocrine Cancer Patients At ASCO | 05 June 2008 |
|
Incyte's Novel JAK Inhibitor Demonstrates Rapid Clinical Benefits In Ongoing Phase I/II Myelofibrosis Study | 05 June 2008 |
|
Curis Announces GDC-0449 Phase I Clinical Data Presented At American Society Of Clinical Oncology Annual Meeting 2008 | 05 June 2008 |
|
Calando Pharmaceuticals Doses First Patient In SiRNA Phase I Clinical Trial | 05 June 2008 |
|
Ipsen And Spirogen's SJG-136 Shows Encouraging Results In The Treatment Of Refractory Solid Tumours At ASCO | 04 June 2008 |
|
Bioinvent And Thrombogenics Report Positive Phase I Results For Anti-Plgf Cancer Therapeutic TB-403 | 04 June 2008 |
|
CSHL Scientists Trace Causal Link Between A Tumor Suppressor Gene And Liver Cancer | 04 June 2008 |
|
ThromboGenics And BioInvent Report Positive Phase I Results For Anti-PlGF Cancer Therapeutic TB-403 | 04 June 2008 |
|
ADVENTRX Presents CoFactor Data At The 2008 Annual Meeting Of The American Society Of Clinical Oncology (ASCO) | 04 June 2008 |
|
EntreMed Presents MKC-1 Phase 2 Data At American Society Of Clinical Oncology Annual Meeting | 04 June 2008 |
|
New Treatment Combination Proves Safe, Effective For Head And Neck Cancer Patients | 03 June 2008 |
|
New Treatment Combination Safe For Pancreatic Cancer Patients | 03 June 2008 |
|
Advances In Cancer Treatment And Quality Of Life | 03 June 2008 |
|
Studies Advance Emerging Field Of "Personalized Medicine" | 03 June 2008 |
|
New Model Predicts Whether Patients Will Be Free Of Renal Cancer 12 Years After Initial Treatment | 03 June 2008 |
|
CDC Analysis Of Pediatric Cancer Data Finds Regional, Racial Disparities In U.S. Incidence Rates | 03 June 2008 |
|
Antidote For Chemotherapy Allergy Allows Cancer Patients To Receive Medicine Safely | 03 June 2008 |
|
US Childhood Cancers Vary By Region, Age, Race And Gender | 03 June 2008 |
|
Kennedy's Brain Surgery A Success Says Hospital | 03 June 2008 |
|
Preliminary Data From Ongoing Phase 1 Data Of Investigational Anti-PD-1 Antibody Presented At American Society Of Clinical Oncology Annual Meeting | 03 June 2008 |
|
New Nexavar Data Presented In Multiple Tumor Types At 44th American Society Of Clinical Oncology Annual Meeting | 03 June 2008 |
|
New Positive Data Announced For NKTR-102 (PEG-irinotecan), Highlights Promise Of Nektar's Innovative Small Molecule PEG-Oncolytics | 03 June 2008 |
|
Exelixis Reports Phase 1 And Phase 2 Data For XL647 At ASCO | 03 June 2008 |
|
Clinical Proof Of Concept For TGF-beta 2-Inhibitor AP 12009 In Phase IIb / EMEA Provides Guidance On Phase III Design And Approval Requirements | 03 June 2008 |
|
Multi Million Dollar Funding Package For Acculis Limited Microwave Cancer Treatment | 03 June 2008 |
|
Xencor To Present New Data From Anti-CD19 Antibody Program At ASCO | 03 June 2008 |
|
First-In-Man Study Of RTA 402 Yields Promising Results In Patients With Advanced Cancers | 03 June 2008 |
|
New Data From Several Satraplatin Clinical Trials In Solid Tumors Presented At 44th ASCO Annual Meeting | 03 June 2008 |
|
Amgen Reports Positive Data At ASCO From Three Studies Of Denosumab In Cancer Patients | 03 June 2008 |
|
Amgen Presents New Data At ASCO On Four Investigational Molecules From Oncology Pipeline | 03 June 2008 |
|
Encouraging Findings From TNFerade(TM) Head And Neck Cancer Study Presented At ASCO | 03 June 2008 |
Back to newsletter list